For patients who have recovered from COVID-19, myocarditis may cause lingering complications, even among seemingly-healthy athletes. COVID-19 will forever be the defining element of 2020. For the vast majority of us, this will mean reflecting on lockdowns, social distancing, masks, and the ...
Perhaps the most common point of conflict concerning COVID-19 vaccines is the risk of myocarditis following immunization, particularly among young people. What do the numbers tell us about COVID-19, vaccines, and myocarditis? What Is Myocarditis? Myocarditis is an inflammation of the heart muscl...
Before COVID-19 the incidence of myocarditis was betweenone and 10 cases per 100,000 people per year. Rates are highest in males between 18 and 30 years old. Interestingly, most cases of myocarditis in thehighest risk group are in otherwise healthy and active people. According to theU.S. ...
Risk factors for myocarditis in COVID‐19 were young age, male sex, pneumonia, and multisystemic inflammatory COVID‐19‐infection. Myocarditis was independently associated with increased case‐fatality.doi:10.1002/jmv.28646Keller, KarstenSagoschen, Ingo...
The evolving bottom line appears to be that there does seem to be a small but real increased risk of myocarditis from the mRNA-based COVID-19 vaccines, but the risk-benefit profile still favors vaccination. Placebo versus the Law of Attraction ...
Similar associations were not observed with any of the COVID-19 vaccines, apart from an increased risk of arrhythmia following a second dose of mRNA-1273. Subgroup analyses by age showed the increased risk of myocarditis associated with the two mRNA vaccines was present only in those younger ...
The risk of acute myocarditis associated with COVID-19 mRNA vaccination has garnered intense (social) media attention. However, myocarditis after COVID-19 mRNA vaccination is rare and usually resolves within days or weeks. Moreover, the risks of hospitalization and death associated with COVID-19...
But of note, Januzzi continued, most of the troponin elevations seen in the COVID-19 setting come in at lower than what’s typically seen with acute MI. “The possibility of myocarditis as an explanation is one potential; some clear cases of COVID-19 myocarditis have been reported, however...
Keywords Myocarditis COVID-19 Vaccines 1. Introduction Myocardial injury has been shown to be prevalent in hospitalized COVID-19 patients, reaching up to 36% of them.[1] The pathogenetic pathway of this myocardial injury in COVID-19 patients is not yet determined, but evidence supporting direct...
The Coronavirus disease 2019 (COVID-19) pandemic, caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has impacted over 200 countries leading to hospitalizations and deaths of millions of people. Public health interventions, such as risk estimators, can reduce the sp...